Literature DB >> 33456691

Etiopathogenesis of Trismus in Patients With Head and Neck Cancer: An Exploratory Literature Review.

Radhu Raj1, Krishnakumar Thankappan2, Chandrasekhar Janakiram3, Subramania Iyer2, Anil Mathew1.   

Abstract

Trismus refers to a person's inability to normally open his or her mouth. Trismus can occur as a symptom due to tumor ingrowth or it can occur postsurgical following the treatment for head and neck cancer. Radiation-induced trismus is also a relatively common oral complication. This review aimed at reviewing the etiopathogenesis of trismus in patients with head and neck cancer. Of the 16 publications included after final screening, of which one was a nonrandomized control trial, one a randomized control trial, 6 prospective cohort studies, and 8 retrospective cohort studies. Among them, 6 articles addressed the possible mechanism for trismus related to tumor ingrowth, 8 articles suggested the likely reason for trismus in patients who had undergone radiation therapy and 2 articles addressed the postsurgical cause for trismus. This review highlights the possible involvement of infratemporal fossa as a predetermining factor for developing trismus related to tumor extension. The molecular mechanism of radiation-induced fibrosis is well studied in the literature.
© The Author(s) 2020.

Entities:  

Keywords:  head and neck cancer; pathogenesis; radiation-induced fibrosis; systematic review; trismus

Year:  2020        PMID: 33456691      PMCID: PMC7797966          DOI: 10.1177/1943387520917518

Source DB:  PubMed          Journal:  Craniomaxillofac Trauma Reconstr        ISSN: 1943-3875


  45 in total

1.  The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients.

Authors:  M Goldstein; W G Maxymiw; B J Cummings; R E Wood
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-09

Review 2.  Intracellular antioxidants: from chemical to biochemical mechanisms.

Authors:  J Chaudière; R Ferrari-Iliou
Journal:  Food Chem Toxicol       Date:  1999 Sep-Oct       Impact factor: 6.023

3.  TRISMUS. ETIOLOGY AND MANAGEMENT OF INABILITY TO OPEN THE MOUTH.

Authors:  G J BEEKHUIS; E B HARRINGTON
Journal:  Laryngoscope       Date:  1965-08       Impact factor: 3.325

Review 4.  Potential targets for intervention in radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

5.  Trismus as a presenting symptom in nasopharyngeal carcinoma.

Authors:  Enis Ozyar; Mustafa Cengiz; Murat Gurkaynak; I Lale Atahan
Journal:  Radiother Oncol       Date:  2005-09-12       Impact factor: 6.280

Review 6.  Fibroblast differentiation in wound healing and fibrosis.

Authors:  Ian A Darby; Tim D Hewitson
Journal:  Int Rev Cytol       Date:  2007

7.  Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress.

Authors:  Yasuhiro Terasaki; Ikuroh Ohsawa; Mika Terasaki; Mikiko Takahashi; Shinobu Kunugi; Kang Dedong; Hirokazu Urushiyama; Shunsuke Amenomori; Mayuko Kaneko-Togashi; Naomi Kuwahara; Arimi Ishikawa; Naomi Kamimura; Shigeo Ohta; Yuh Fukuda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-15       Impact factor: 5.464

Review 8.  Trismus in patients with head and neck cancer: etiopathogenesis, diagnosis and management.

Authors:  A D Rapidis; P U Dijkstra; J L N Roodenburg; J P Rodrigo; A Rinaldo; P Strojan; R P Takes; A Ferlito
Journal:  Clin Otolaryngol       Date:  2015-12       Impact factor: 2.597

9.  MRI findings in patients with severe trismus following radiotherapy for nasopharyngeal carcinoma.

Authors:  Kunwar S S Bhatia; Ann D King; Bhawan K Paunipagar; Jill Abrigo; Alexander C Vlantis; Sing F Leung; Anil T Ahuja
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

10.  The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer.

Authors:  Nina Pauli; Joakim Johnson; Caterina Finizia; Paulin Andréll
Journal:  Acta Oncol       Date:  2012-11-29       Impact factor: 4.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.